Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (3827)	2/14/1998 11:23:00 AM
From: Henry Niman	Respond to of 6136

Sam, LGND's bid actually move to $17 on Thursday (but it opened at $16). I expect LGND to continue to head north on continuing good news. Yesterday Lehman Bothers and Robertson Stephens came out with updates, and both are EXTREMELY bullish. Looks like it's going to be a very good year. LGND will be presenting at the International AIDS conference in Geneva in June. By then they should really be on a roll (somewhere in the 20's). I did start a Biotech Boom table at home.att.net , but so far it's almost all LGND (three major stories in one week is a lot).